WallStSmart

Forian Inc (FORA)vsHealthEquity Inc (HQY)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

HealthEquity Inc generates 4350% more annual revenue ($1.34B vs $30.05M). HQY leads profitability with a 17.2% profit margin vs -17.0%. FORA appears more attractively valued with a PEG of 0.94. HQY earns a higher WallStSmart Score of 66/100 (B-).

FORA

Avoid

29

out of 100

Grade: F

Growth: 4.7Profit: 2.0Value: 6.0Quality: 5.0

HQY

Strong Buy

66

out of 100

Grade: B-

Growth: 8.0Profit: 7.5Value: 6.7Quality: 7.8
Piotroski: 7/9
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for FORA.

HQYUndervalued (+49.2%)

Margin of Safety

+49.2%

Fair Value

$151.32

Current Price

$88.67

$62.65 discount

UndervaluedFair: $151.32Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

FORA2 strengths · Avg: 8.0/10
PEG RatioValuation
0.948/10

Growing faster than its price suggests

Price/BookValuation
2.3x8/10

Reasonable price relative to book value

HQY2 strengths · Avg: 8.0/10
Operating MarginProfitability
29.3%8/10

Strong operational efficiency at 29.3%

EPS GrowthGrowth
34.4%8/10

Earnings expanding 34.4% YoY

Areas to Watch

FORA4 concerns · Avg: 2.3/10
Market CapQuality
$67.79M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.9%2/10

ROE of -17.9% — below average capital efficiency

Revenue GrowthGrowth
-2.9%2/10

Revenue declined 2.9%

EPS GrowthGrowth
-89.1%2/10

Earnings declined 89.1%

HQY1 concerns · Avg: 4.0/10
P/E RatioValuation
33.1x4/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : FORA

The strongest argument for FORA centers on PEG Ratio, Price/Book. PEG of 0.94 suggests the stock is reasonably priced for its growth.

Bull Case : HQY

The strongest argument for HQY centers on Operating Margin, EPS Growth. Profitability is solid with margins at 17.2% and operating margin at 29.3%. PEG of 1.27 suggests the stock is reasonably priced for its growth.

Bear Case : FORA

The primary concerns for FORA are Market Cap, Return on Equity, Revenue Growth.

Bear Case : HQY

The primary concerns for HQY are P/E Ratio.

Key Dynamics to Monitor

FORA profiles as a turnaround stock while HQY is a mature play — different risk/reward profiles.

FORA carries more volatility with a beta of 0.93 — expect wider price swings.

HQY is growing revenue faster at 7.2% — sustainability is the question.

HQY generates stronger free cash flow (97M), providing more financial flexibility.

Bottom Line

HQY scores higher overall (66/100 vs 29/100), backed by strong 17.2% margins. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Forian Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Forian Inc. provides a suite of software solutions, data management capabilities, proprietary data, and predictive analytics to optimize and measure operational, clinical, and financial performance for clients in the health and cannabis industries, as well as dispensaries. , cannabis growers, manufacturers, and distributors. The company is headquartered in Newtown, Pennsylvania.

HealthEquity Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

HealthEquity, Inc. provides technology-enabled service platforms to consumers and employers in the United States. The company is headquartered in Draper, Utah.

Want to dig deeper into these stocks?